Eldaabossi Safwat, Al-Ghoneimy Yasser, Ghoneim Ayman, Awad Amgad, Mahdi Waheed, Farouk Abdallah, Soliman Hesham, Kanany Hatem, Antar Ahmad, Gaber Yasser, Shaarawy Ahmed, Nabawy Osama, Atef Moaz, Nour Sameh O, Kabil Ahmed
Department of Chest Diseases, Al-Azhar University, Cairo, Egypt.
Pulmonology Department, Almoosa Specialist Hospital, Al Ahsa, Saudi Arabia.
J Multidiscip Healthc. 2023 Mar 6;16:625-634. doi: 10.2147/JMDH.S404124. eCollection 2023.
Pulmonary complications after thoracic surgery are common and are associated with prolonged hospital stay, higher costs, and increased mortality. This study aimed to evaluate the value of The Assess Respiratory risk in Surgical Patients in Catalonia (ARISCAT) risk index in predicting pulmonary complications after thoracic surgery.
This retrospective study was conducted at Almoosa Specialist Hospital, Saudi Arabia, from August 2016 to August 2019 and included 108 patients who underwent thoracic surgery during the study period. Demographic data, ARISCAT risk index score, length of hospital stay, time of chest tube removal, postoperative complications, and time of discharge were recorded.
The study involved 108 patients who met the inclusion criteria. Their mean age was 42.5 ± 18.9 years, and most of them were men (67.6%). Comorbid diseases were present in 53.7%, including mainly type 2 diabetes mellitus and hypertension. FEV1% was measured in 58 patients, with a mean of 71.1 ± 7.3%. The mean ARISCAT score was 39.3 ± 12.4 and ranged from 24 to 76, with more than one-third (35.2%) having a high score grade. The most common surgical procedures were thoracotomy in 47.2%, video-assisted thoracoscopic surgery (VATS) in 28.7%, and mediastinoscopy in 17.6%. Postoperative pulmonary complications (PPCs) occurred in 22 patients (20.4%), mainly pneumonia and atelectasis (9.2%). PPCs occurred most frequently during thoracotomy (68.2%), followed by VATS (13.6%), and mediastinoscopy (9.1%). Multinomial logistic regression of significant risk factors showed that lower FEV1% (OR = 0.88 [0.79-0.98]; p=0.017), longer ICU length of stay (OR = 1.53 [1.04-2.25]; p=0.033), a higher ARISCAT score (OR = 1.22 [1.02-1.47]; p=0.040), and a high ARISCAT grade (OR = 2.77 [1.06-7.21]; p=0.037) were significant predictors of the occurrence of postoperative complications.
ARISCAT scoring system, lower FEV1% score, and longer ICU stay were significant predictors of postoperative complications. In addition, thoracotomy was also found to be associated with PPCs.
胸外科手术后肺部并发症很常见,与住院时间延长、费用增加和死亡率上升相关。本研究旨在评估加泰罗尼亚外科患者呼吸风险评估(ARISCAT)风险指数在预测胸外科手术后肺部并发症方面的价值。
本回顾性研究于2016年8月至2019年8月在沙特阿拉伯的阿尔穆萨专科医院进行,纳入了研究期间接受胸外科手术的108例患者。记录了人口统计学数据、ARISCAT风险指数评分、住院时间、胸管拔除时间、术后并发症及出院时间。
该研究纳入了108例符合纳入标准的患者。他们的平均年龄为42.5±18.9岁,大多数为男性(67.6%)。53.7%的患者存在合并症,主要包括2型糖尿病和高血压。对58例患者进行了第一秒用力呼气容积百分比(FEV1%)测量,平均值为71.1±7.3%。ARISCAT评分的平均值为39.3±12.4,范围为24至76,超过三分之一(35.2%)的患者为高分等级。最常见的手术方式为开胸手术(47.2%)、电视辅助胸腔镜手术(VATS,28.7%)和纵隔镜检查(17.6%)。22例患者(20.4%)发生了术后肺部并发症(PPCs),主要为肺炎和肺不张(9.2%)。PPCs在开胸手术期间发生最为频繁(68.2%),其次是VATS(13.6%)和纵隔镜检查(9.1%)。对显著风险因素进行的多项逻辑回归分析显示,较低的FEV1%(比值比[OR]=0.88[0.79 - 0.98];p=0.017)、较长的重症监护病房(ICU)住院时间(OR = 1.53[1.04 - 2.25];p=0.033)、较高的ARISCAT评分(OR = 1.22[1.02 - 1.47];p=0.040)和较高的ARISCAT等级(OR = 2.77[1.06 - 7.21];p=0.037)是术后并发症发生的显著预测因素。
ARISCAT评分系统、较低的FEV1%评分和较长的ICU住院时间是术后并发症的显著预测因素。此外,还发现开胸手术与PPCs有关。